Level:
Correct: 0
Incorrect: 0
Marks: 0/0
Exam Practice
Course:
Topics:
Edexcel GCSE History (Medicine in Britain c1250-present) Smart practice A mixed round aimed at your weak spots
Unit 1
c1250-c1500: Medicine in medieval England
Unit 2
c1500-c1700: The Medical Renaissance in England
Unit 3
c1700-c1900: Medicine in eighteenth- and nineteenth-century Britain
Unit 4
c1900-present: Medicine in modern Britain
Unit 5
Historic environment: The British sector of the Western Front, 1914-18: injuries, treatment and the trenches
Avg
score:
–
Topics
done:
0/17

Case studies: penicillin and the fight against lung cancer

Practise 20 exam-style questions on Case studies: penicillin and the fight against lung cancer for Edexcel GCSE History (Medicine in Britain c1250-present). Write your answer as you would in the exam and get it marked in seconds against the mark scheme, point by point, with the Study Helper on hand if you get stuck.

  • 20 questions
  • 4–20 marks each
  • Instant marking
  • No sign-up needed
20 questions, marked as you go

Sample questions with model answers

Here are 4 of the questions in this topic, each with a model answer, an explanation of why it earns the marks and the mark scheme an examiner would use.

Question 1

4 marks

Explain one way in which the sharing of new medical discoveries in the years c1500-c1700 was similar to the sharing of knowledge about penicillin in the years 1929-45.

Model answer

One similarity is that in both periods new discoveries were shared through print, which allowed other scientists to read them and build on them, although this could be slow. In the years c1500-c1700, Vesalius's Fabric of the Human Body (1543) was printed and copied in England by Thomas Geminus in 1545, and the Royal Society published reports of experiments in its Philosophical Transactions from 1665. Similarly, Fleming described penicillin in an article in the British Journal of Experimental Pathology in 1929. Few people took notice at first, but nearly ten years later Ernst Chain read the article in Oxford, and it led to the team's work on penicillin. The Oxford team then published their results in The Lancet in 1940 and 1941, and these articles were read by scientists in the USA, which helped knowledge of penicillin to spread.

Explanation

The best answers name the similarity (printed publications that others could build on) and support it with a specific example from each period, such as Vesalius's book and Fleming's 1929 article. Answers that only say 'ideas spread in both periods' are generalised and stay in Level 1. Do not drift into a difference, such as the speed of modern communication, when the question asks for a similarity.

Mark scheme
  1. 4 marks

    Levels of response (4 marks). AO2: 2 marks. AO1: 2 marks.
    Level 2 (3-4 marks): Features of the period are analysed to explain a similarity. [AO2] Specific information about the topic is added to support the comparison, showing good knowledge and understanding of the periods. [AO1]
    Level 1 (1-2 marks): Simple or generalised comment is offered about a similarity. [AO2] Generalised information about the topic is included, showing limited knowledge and understanding of the periods. [AO1]
    0 marks: No rewardable material.
    Performance in AO1 and AO2 is interdependent. An answer displaying no qualities of AO2 cannot be awarded more than the top of Level 1, no matter how strong performance is in AO1; markers should note that the expectation for AO1 is that candidates demonstrate both knowledge and understanding.

    Indicative content (not a checklist; credit other valid points): Valid similarities, each needing specific information from both periods for Level 2: (1) Printed publications let other scientists read and build on new work: Vesalius's Fabric of the Human Body (1543), copied in England by Thomas Geminus (1545); Harvey's De Motu Cordis (1628); the Royal Society's Philosophical Transactions (from 1665); Fleming's article in the British Journal of Experimental Pathology (1929), which Chain read in Oxford in 1938-39; the Oxford team's articles in The Lancet (1940 and 1941), read by scientists in the USA and elsewhere. (2) New knowledge was often ignored or slow to have an effect at first: many physicians rejected Harvey's ideas for years and treatment changed little; Fleming's 1929 article attracted little attention for nearly ten years, and the 1940 Lancet article was slow to win support. (3) Meetings and societies of scientists spread knowledge: members of the Royal Society (1660) watched experiments and discussed them; Fleming presented his findings to the Medical Research Club; Florey and Heatley's visit to the USA in 1941 shared the Oxford methods with American scientists. (4) Knowledge crossed borders: Vesalius worked in Padua and Harvey trained there; knowledge of penicillin passed between Britain and the USA. Level 1: a generalised similarity (e.g. 'ideas spread in both periods') or detail about only one period. Printed news-sheets and the London Gazette (from 1665-66) may be credited for c1500-c1700. Do not credit: claims that radio or television existed in c1500-c1700; differences.

Question 2

12 marks

Explain why Florey and Chain's team was able to develop penicillin into a usable medicine in the years 1938-41.

You may use the following in your answer:
- funding from the Rockefeller Foundation
- Norman Heatley's production methods

You must also use information of your own.

Model answer

Florey and Chain's team succeeded because they had a planned research programme, a team with the right skills, enough funding and a scientific method of testing that proved penicillin worked.

First, their work was part of a systematic search for natural substances that killed bacteria. In 1938-39, at Oxford's Sir William Dunn School of Pathology, Chain came across Fleming's largely forgotten article of 1929, and the team chose penicillin as one of the substances to investigate. Unlike Fleming, they set out from the start to study it in depth.

Second, the team brought together experts from different fields. Florey was a pathologist and a determined organiser. Chain, a biochemist who had left Nazi Germany in 1933, solved chemical problems: he suggested using freeze-drying, a new technique, to turn the penicillin solution into a stable powder. Others, such as Edward Abraham and Margaret Jennings, worked on its chemistry and on tests in animals. This kind of teamwork was unusual in Britain at the time.

Norman Heatley's production methods were also vital. Because the mould needed air and a large surface, he grew it in bedpans and then in specially made ceramic vessels. He invented a method of 'reverse extraction', which moved the penicillin out of the solvent and back into water, and a way of measuring its strength. This meant the team could make enough penicillin for experiments.

Funding from the Rockefeller Foundation made this possible. The Medical Research Council gave only small grants, but the American foundation agreed to provide 5,000 dollars a year for five years. This paid for the equipment and chemicals that a long research programme needed.

Next, the team used careful experiments to prove that penicillin worked. On 25 May 1940 Florey injected eight mice with deadly streptococcus bacteria and then gave penicillin to four of them. By the next morning all four untreated mice were dead, but the treated mice were still alive. The results, published in The Lancet in August 1940, were repeated with more mice and different bacteria.

Finally, the team tested penicillin on people. In February 1941 an Oxford policeman, Albert Alexander, who had a severe infection, improved dramatically after being given penicillin. The supply ran out and he died in March, but his recovery showed what the drug could do. The team then treated children, who needed smaller doses, and several recovered fully.

The Second World War also gave the work urgency, because infected wounds were a major threat to soldiers. Together, skilled teamwork, funding and scientific testing turned Fleming's observation into a usable medicine.

Explanation

Top answers explain how each factor helped the team succeed, for example how freeze-drying or Heatley's equipment solved the problem of production, rather than simply narrating events. They cover at least three aspects of content, such as funding, teamwork, the mouse experiment and the first human trials. A common error is to say that Albert Alexander was cured: he improved, but died when the supply ran out.

Mark scheme
  1. 12 marks

    Levels of response (12 marks). AO2: 6 marks. AO1: 6 marks.
    Level 4 (10-12 marks): An analytical explanation is given which is directed consistently at the conceptual focus of the question, showing a line of reasoning that is coherent, sustained and logically structured. [AO2] Accurate and relevant information is precisely selected to address the question directly, showing wide-ranging knowledge and understanding of the required features or characteristics of the period studied. [AO1] No access to Level 4 for answers that do not address three or more aspects of content.
    Level 3 (7-9 marks): An explanation is given, showing some analysis, which is mainly directed at the conceptual focus of the question. It shows a line of reasoning that is generally sustained, although some passages may lack coherence and organisation. [AO2] Accurate and relevant information is included, showing good knowledge and understanding of the required features or characteristics of the period studied. [AO1] Maximum 8 marks for answers that do not address three or more aspects of content.
    Level 2 (4-6 marks): An explanation is given, showing limited analysis and with implicit or unsustained links to the conceptual focus of the question. It shows some development and organisation of material, but a line of reasoning is not sustained. [AO2] Accurate and relevant information is included, showing some knowledge and understanding of the period. [AO1]
    Level 1 (1-3 marks): A simple or generalised answer is given, lacking development and organisation. [AO2] Limited knowledge and understanding of the topic is shown. [AO1]
    0 marks: No rewardable material.
    Performance in AO1 and AO2 is interdependent. An answer displaying no qualities of AO2 cannot be awarded more than the top of Level 1, no matter how strong performance is in AO1; markers should note that the expectation for AO1 is that candidates demonstrate both knowledge and understanding.

    Indicative content (not a checklist; credit other valid points): Answers may explain: (1) A planned research programme: in 1938-39, at Oxford's Sir William Dunn School of Pathology, Florey and Chain began a systematic study of natural antibacterial substances; Chain found Fleming's largely forgotten 1929 article, and penicillin was chosen as one of three substances to study. (2) Teamwork and expertise: Florey (pathologist, leader and organiser); Chain (biochemist who had left Nazi Germany in 1933), who suggested amyl acetate as a safer solvent and freeze-drying, a new technique, to obtain a stable powder; Edward Abraham (chemistry), Margaret Jennings (animal tests), and others; such teamwork was unusual in Britain at the time. (3) Funding: the Medical Research Council gave only small grants (it also paid the wages of the women assistants who tended the mould cultures); the Rockefeller Foundation, an American charity, provided 5,000 dollars a year for five years (from 1939-40), paying for equipment, chemicals and research. (4) Heatley's production methods: growing mould in bedpans and then specially made ceramic vessels (collected from December 1940); 'reverse extraction' to move penicillin from the solvent back into water; an assay (the Oxford unit) to measure strength. (5) Scientific testing: toxicity tests on animals (March-May 1940); the mouse experiment of 25 May 1940 (eight mice infected with streptococci; the four untreated mice were dead by the early hours of the next morning, while the treated mice were still alive), repeated with larger numbers and other bacteria; results published in The Lancet (24 August 1940). (6) Trials on people: PC Albert Alexander improved dramatically from 12 February 1941 but died in March when supplies ran out (penicillin was even recovered from his urine); children, who needed smaller doses, were then treated and several recovered; results published in The Lancet (August 1941). (7) Context: germ theory and the success of sulphonamides showed that chemicals could kill bacteria inside the body; the Second World War made a cure for infected wounds urgent, although it also made resources scarce. Answers that describe the team's work without explaining why it succeeded should not go beyond Level 2. Do not credit: claims that Fleming was part of the Oxford team; claims that Albert Alexander was cured; claims that the team had mass-produced penicillin by 1941.

    Pearson's marking instructions: The middle mark in each level may be achieved by stronger performance in either AO1 or AO2.

Question 3

12 marks

Explain why the treatment of lung cancer changed in the twenty-first century.

You may use the following in your answer:
- immunotherapy
- keyhole surgery

You must also use information of your own.

Model answer

The treatment of lung cancer changed in the twenty-first century because scientists understood more about how cancer cells grow, new technology made surgery and radiotherapy more precise, and the NHS was able to diagnose more cancers early.

The most important reason was new scientific knowledge about cancer cells. Research in genetics, helped by the Human Genome Project (2003), showed that many lung cancers are driven by changes in particular genes, such as EGFR or ALK. This led to targeted drugs that block the signals these cancer cells need to grow. Doctors test a sample of the tumour to find which gene change it has and then choose the right drug. For example, NICE recommended gefitinib for NHS use in 2010 and osimertinib in 2020 for people whose cancer has an EGFR change.

Research into the immune system led to immunotherapy. Scientists discovered that some cancer cells use proteins to switch off the body's immune cells. Drugs called checkpoint inhibitors, such as pembrolizumab, block this, so that the immune system can attack the cancer. These drugs have helped some people with advanced lung cancer live longer, and they are now also used before or after surgery.

Technology also changed surgery. Keyhole surgery, called video-assisted thoracoscopic surgery, uses a camera and a few small cuts instead of opening the chest, and some hospitals use robot-assisted surgery. Patients have less pain and recover more quickly, so more people, including older patients, can have an operation to remove part of a lung.

Radiotherapy became more precise as well. Stereotactic radiotherapy uses CT scans to plan very accurate high doses aimed at a small tumour, given in only a few sessions. It is now the usual treatment for early lung cancer when a patient is not fit enough for surgery.

Earlier diagnosis also changed treatment. Lung health checks and the national screening programme found more cancers at stage 1 or 2, when surgery or stereotactic radiotherapy can aim to cure the cancer rather than only slow it down.

Finally, institutions made these changes possible. Drug companies, universities and charities such as Cancer Research UK carried out clinical trials, NICE decided which new treatments the NHS should pay for, and the NHS provided them free. The government's National Cancer Plan for England (2026) aims for three in four people diagnosed with cancer to survive for at least five years by 2035.

Explanation

Top answers explain what made each change possible, for example how knowledge of gene changes led to targeted drugs, instead of describing the treatments. They go beyond the stimulus points to cover at least three aspects of content, such as radiotherapy, earlier diagnosis or the role of NICE and the NHS. Avoid overclaiming: these treatments have improved survival, but many lung cancers are still found too late to be cured.

Mark scheme
  1. 12 marks

    Levels of response (12 marks). AO2: 6 marks. AO1: 6 marks.
    Level 4 (10-12 marks): An analytical explanation is given which is directed consistently at the conceptual focus of the question, showing a line of reasoning that is coherent, sustained and logically structured. [AO2] Accurate and relevant information is precisely selected to address the question directly, showing wide-ranging knowledge and understanding of the required features or characteristics of the period studied. [AO1] No access to Level 4 for answers that do not address three or more aspects of content.
    Level 3 (7-9 marks): An explanation is given, showing some analysis, which is mainly directed at the conceptual focus of the question. It shows a line of reasoning that is generally sustained, although some passages may lack coherence and organisation. [AO2] Accurate and relevant information is included, showing good knowledge and understanding of the required features or characteristics of the period studied. [AO1] Maximum 8 marks for answers that do not address three or more aspects of content.
    Level 2 (4-6 marks): An explanation is given, showing limited analysis and with implicit or unsustained links to the conceptual focus of the question. It shows some development and organisation of material, but a line of reasoning is not sustained. [AO2] Accurate and relevant information is included, showing some knowledge and understanding of the period. [AO1]
    Level 1 (1-3 marks): A simple or generalised answer is given, lacking development and organisation. [AO2] Limited knowledge and understanding of the topic is shown. [AO1]
    0 marks: No rewardable material.
    Performance in AO1 and AO2 is interdependent. An answer displaying no qualities of AO2 cannot be awarded more than the top of Level 1, no matter how strong performance is in AO1; markers should note that the expectation for AO1 is that candidates demonstrate both knowledge and understanding.

    Indicative content (not a checklist; credit other valid points): Answers may explain: (1) Genetics and targeted drugs: research into the gene changes that drive some lung cancers (e.g. EGFR, ALK, ROS1, KRAS), helped by the Human Genome Project (2003), led to targeted drugs that block the signals cancer cells need to grow, matched to each tumour by genetic testing: e.g. gefitinib (recommended by NICE for first-line NHS use in July 2010), osimertinib (October 2020 for untreated EGFR-positive cancer; now also used after surgery), alectinib for ALK changes. (2) Immunotherapy: research into how cancer cells switch off the immune system led to checkpoint inhibitors (PD-1 and PD-L1 drugs) such as pembrolizumab (recommended by NICE for routine NHS use in July 2018 for untreated PD-L1-positive advanced cancer), nivolumab, atezolizumab and durvalumab, used for advanced cancer and increasingly before or after surgery. (3) Keyhole and robotic surgery: video-assisted thoracoscopic surgery (VATS) removes small early cancers through one to three small cuts using a camera; robot-assisted surgery is also used; less pain and quicker recovery mean more patients can have surgery; lobectomy is the most common operation for early-stage cancer. (4) Radiotherapy technology: stereotactic ablative radiotherapy (SABR) gives very precise high doses in 3 to 8 sessions, planned with CT scans, and is the usual treatment for stage 1-2A non-small cell lung cancer when surgery is not possible. (5) Earlier diagnosis through lung health checks and screening means more patients are found at a stage when treatment can aim to cure. (6) Institutions and funding: clinical trials run by drug companies, universities and charities such as Cancer Research UK; NICE decides which treatments the NHS funds, and the NHS provides them free; the National Cancer Plan for England (2026) aims for 75% of people diagnosed with cancer to survive five years or more by 2035. (7) Combined treatment: chemoradiotherapy, and drugs given before or after surgery. Answers that describe treatments without explaining why they changed should not go beyond Level 2. Do not credit: claims that lung cancer can now always be cured, or that targeted drugs and immunotherapy work for every patient (they depend on the features of each cancer); claims that antibiotics treat cancer.

    Pearson's marking instructions: The middle mark in each level may be achieved by stronger performance in either AO1 or AO2.

Question 4

20 marks

'In the years c1900-present, medicine has been far more successful in treating bacterial infections than in treating lung cancer.'

How far do you agree? Explain your answer.

You may use the following in your answer:
- penicillin-resistant bacteria
- the late diagnosis of lung cancer

You must also use information of your own.

Spelling, punctuation, grammar and use of specialist terminology will be assessed in this question.

Model answer

Medicine has been far more successful in treating bacterial infections than in treating lung cancer, although the rise of resistant bacteria and recent improvements in lung cancer treatment mean that the gap is not as wide as it once was.

The success against bacterial infection was dramatic. Before the 1940s, infections such as septicaemia, pneumonia and meningitis often killed, and even a small wound could be fatal. Penicillin, developed by Florey and Chain's team in 1940-41 and mass-produced from 1943-44, changed this. During the Allied campaign in Europe in 1944-45, gas gangrene in wounds almost disappeared, and after the war many more antibiotics followed. Tablets or injections now cured illnesses that had killed people for centuries.

By contrast, lung cancer is still the UK's most common cause of cancer death, with around 32,800 deaths a year in 2022-24. Only about 11% of patients diagnosed in 2018 were expected to survive for ten years or more. The main reason is late diagnosis. Lung cancer usually causes no symptoms until it has spread, and in 2022 only about a third of cases in England were found at stage 1 or 2. Government figures in 2023 showed that when it is found at stage 4, only about 4 in 100 people survive for five years, because surgery and radiotherapy can no longer remove all of the cancer.

However, the success against bacteria has been weakened by penicillin-resistant bacteria. Fleming himself warned in 1945 that misusing penicillin would allow resistant bacteria to survive. Resistance soon appeared: at Hammersmith Hospital in London, the share of staphylococci resistant to penicillin tripled between 1946 and early 1947, and MRSA was first reported in Britain in 1961. Some infections are now hard to treat again, and antibiotics have never worked against viruses. Success against infection is therefore neither complete nor permanent.

At the same time, the treatment of lung cancer has improved in the twenty-first century. By 2023, lung health checks, which began in 2019, had found 76% of cancers at an earlier stage, when about 60% of people survive for five years. Keyhole surgery and stereotactic radiotherapy can remove or destroy early tumours, and newer drugs help some people with advanced cancer live longer. Lung cancer death rates fell by about two-fifths between the early 1970s and 2022-24, although much of this is because fewer people smoke rather than because of better treatment.

The fairest criterion is the proportion of patients who can be cured. By this measure, antibiotics are far more successful: most people with a bacterial infection recover quickly, whereas most people with lung cancer are still diagnosed too late to be cured. Also, cancer, which grows from the body's own cells, is a much harder target than bacteria, so the comparison is not entirely fair.

Overall, I agree with the statement. Penicillin turned many deadly infections into curable ones, while lung cancer remains a leading killer. However, resistance threatens the success of antibiotics, and earlier diagnosis is beginning to narrow the gap.

Explanation

This statement compares the two case studies, so top answers give balanced, precise evidence on both: what penicillin achieved and how resistance has limited it, and what modern lung cancer treatment can and cannot do. Answers that write only about penicillin or only about lung cancer cannot reach the top level. A clear criterion, such as the proportion of patients cured, helps to make the final judgement convincing.

Mark scheme
  1. 16 marks

    Levels of response (16 marks).
    Level 4 (13-16 marks): An analytical explanation is given which is directed consistently at the conceptual focus of the question, showing a line of reasoning that is coherent, sustained and logically structured. Accurate and relevant information is precisely selected to address the question directly, showing wide-ranging knowledge and understanding of the required features or characteristics of the period studied. Criteria for the required judgement are justified and applied in the process of reaching the overall judgement. No access to Level 4 for answers that do not address three or more aspects of content.
    Level 3 (9-12 marks): An explanation is given, showing some analysis, which is mainly directed at the conceptual focus of the question. It shows a line of reasoning that is generally sustained, although some passages may lack coherence and organisation. Accurate and relevant information is included, showing good knowledge and understanding of the required features or characteristics of the period studied. The overall judgement is given with some justification, but some criteria selected for the required judgement are left implicit or not validly applied. Maximum 11 marks for answers that do not address three or more aspects of content.
    Level 2 (5-8 marks): An explanation is given showing limited analysis and with implicit or unsustained links to the conceptual focus of the question. It shows some development and organisation of material, but a line of reasoning is not sustained. Accurate and relevant information is included, showing some knowledge and understanding of the period. The overall judgement is given but its justification is asserted or insecure.
    Level 1 (1-4 marks): A simple or generalised answer is given, lacking development and organisation. Limited knowledge and understanding of the topic is shown. The overall judgement is missing or asserted.
    0 marks: No rewardable material.

    Indicative content (not a checklist; credit other valid points): Points that support the statement: penicillin, mass-produced from 1943-44, cured many bacterial infections quickly and cheaply (septicaemia, pneumonia, meningitis, infected wounds, gonorrhoea); gas gangrene almost disappeared among Allied wounded in 1944-45; many more antibiotics followed and deaths from bacterial infection fell sharply; lung cancer is still the UK's most common cause of cancer death (around 32,800 deaths a year, 2022-24); about 11% of patients survive ten years or more (diagnosed 2018); late diagnosis: in 2022 only 34% of cases in England with a known stage were found at stage 1 or 2, and only about 4% of people diagnosed at stage 4 survive five years (government figures, 2023). Points that counter the statement: resistance: Fleming warned in his Nobel lecture (1945) that misuse would produce resistant bacteria; at Hammersmith Hospital, Mary Barber found that the share of penicillin-resistant staphylococci rose from about one in eight (1946) to about three times that by early 1947; MRSA was first reported in Britain in 1961; antibiotics do not work on viruses; lung cancer treatment has improved: screening (lung health checks from 2019; national programme announced 2023, full rollout by 2030) finds more cancers early, when about 60% of people diagnosed at stage 1 survive five years (2023); keyhole and robotic surgery, stereotactic radiotherapy, targeted drugs (e.g. osimertinib) and immunotherapy (e.g. pembrolizumab) extend or save lives; lung cancer death rates fell by about 40% from the early 1970s to 2022-24, though much of this came from less smoking rather than treatment; cancer is a much harder target than bacteria, so the comparison is not like for like. Criteria: the proportion of patients cured; how long success lasted; the number of lives saved. A substantiated judgement might agree, because antibiotics turned many deadly infections into curable ones while most lung cancers are still found too late to cure, while recognising that resistance threatens this success and earlier diagnosis is narrowing the gap. Do not credit: claims that penicillin cures cancer or viral infections; claims that lung cancer can now always be cured.

    Pearson's marking instructions (part of the mark scheme): AO2: 10 marks. AO1: 6 marks. In each level the first bullet point (the explanation and line of reasoning) is [AO2], the second (the information, knowledge and understanding) is [AO1] and the third (the overall judgement) is [AO2]. Performance in AO1 and AO2 is interdependent. An answer displaying no qualities of AO2 cannot be awarded more than the top of Level 1, no matter how strong performance is in AO1; markers should note that the expectation for AO1 is that candidates demonstrate both knowledge and understanding. The first two bullet points [AO1 and AO2] account for 3 of the 4 marks in the level and are equally weighted; the third bullet point [AO2] accounts for the remaining mark. Once the level has been found, there are two steps to follow to determine the mark within the level: Markers should consider bullet points 1 and 2 together. Strong performance (for the level) in both would be awarded all 3 marks, while 2 marks may be achieved by stronger performance in either bullet point; weak performance would be awarded 1 mark. The fourth mark in each level is allocated to the bullet point 3 and should be considered independently of the award of the other marks.

  2. 4 marks

    SPaG. Spelling, punctuation, grammar and the use of specialist terminology (4 marks).
    High performance (4 marks): Learners spell and punctuate with consistent accuracy. Learners use rules of grammar with effective control of meaning overall. Learners use a wide range of specialist terms as appropriate.
    Intermediate performance (2-3 marks): Learners spell and punctuate with considerable accuracy. Learners use rules of grammar with general control of meaning overall. Learners use a good range of specialist terms as appropriate.
    Threshold performance (1 mark): Learners spell and punctuate with reasonable accuracy. Learners use rules of grammar with some control of meaning and any errors do not significantly hinder meaning overall. Learners use a limited range of specialist terms as appropriate.
    0 marks: The learner writes nothing. The learner's response does not relate to the question. The learner's achievement in SPaG does not reach the threshold performance level, e.g. errors in spelling, punctuation and grammar severely hinder meaning.

    SPaG is marked separately from the 16 marks for the answer, on the whole response.

Ready to try the rest? Every answer you write is marked against the mark scheme, so you can see exactly where the marks are.

Study Helper Hints first, answers after you try

Stuck on this one? Ask for a hint and I’ll point you in the right direction, without giving the answer away. Once you’ve checked your answer, I’ll show you how the marks are awarded.